Brought to you by 
Transgene sells Tasly its stake in Transgene Tasly (Tianjin) JV
06 Aug 2020
Executive Summary
Transgene SA is selling Tasly Biopharmaceuticals Co. Ltd. its 50% stake of their equally owned Transgene Tasly (Tianjin) BioPharmaceutical Co. virus-based immunotherapies joint venture (formed in 2010), giving Tasly a 100% ownership of the JV.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Intra-Biotech Deal
- Partial Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Transgene sells Tasly its stake in Transgene Tasly (Tianjin) JV
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice